Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria

International Journal of Cancer

Volumn 131, Issue 12, 2012, Pages 2903-2909

  Gage, Julia C ^a   Ajenifuja, Kayode O ^b   Wentzensen, Nicolas ^a   Adepiti, Akinfolarin C ^b   Stoler, Mark ^c   Eder, Paul S ^d   Bell, Laura ^d   Shrestha, Niwashin ^d   Eklund, Claire ^e   Reilly, Mary ^e   Hutchinson, Martha ^e   Wacholder, Sholom ^a   Castle, Philip E ^f   Burk, Robert D ^g   Schiffman, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c UNIVERSITY OF VIRGINIA   (United States)

^d QIAGEN North America   (United States)

^e WOMEN AND INFANTS HOSPITAL   (United States)

^f American Society for Clinical Pathology   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cervical cancer prevention; HPV DNA testing; screening; test accuracy

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; EDUCATION PROGRAM; FEMALE; GENOTYPE; HEALTH EDUCATION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; INTRARATER RELIABILITY; LABORATORY PERSONNEL; MAJOR CLINICAL STUDY; NIGERIA; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERFORMANCE MEASUREMENT SYSTEM; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RURAL POPULATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STANDARD; TUMOR BIOPSY; TUMOR VIRUS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BIOPSY; DNA, VIRAL; FEMALE; HUMANS; NIGERIA; REAGENT KITS, DIAGNOSTIC; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 84867892926     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27563     Document Type: Article

References (17)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D,. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2008.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N,. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
3. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM,. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64.
4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ,. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
5. Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM,. Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer 2011; 128: 2765-74.
6. Gustafsson L, Ponten J, Zack M, Adami HO,. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755-63.
7. Gustafsson L, Ponten J, Bergstrom R, Adami HO,. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997; 71: 159-65.
8. Denny L, Quinn M, Sankaranarayanan R,. Chapter 8: screening for cervical cancer in developing countries. Vaccine 2006; 24 (Suppl 3): S3/71-7.
9. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
10. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72.
11. Gravitt PE, Belinson JL, Salmeron J, Shah KV,. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 2011; 129: 517-27.
12. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 929-36.
13. Jeronimo J, Poli UR,. Self-Sampling for careHPV™ DNA testing in Hyderabad AOGIN Interim Meeting, Bali, Indonesia, 2011.
14. Jeronimo J, Amador J, Lim J, Paul P,. P-448: performance and acceptability of the vaginal self-collected sample for careHPV(TM) testing in Nicaragua 26th International Papillomavirus Conference Montreal, Canada, 2010.
15. Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M,. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer 2012; 130: 2111-7.
16. Schiffman M, Wacholder S,. From India to the world-a better way to prevent cervical cancer. N Engl J Med 2009; 360: 1453-5.
17. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmeron J, Uribe P, Velasco-Mondragon E, Nevarez PH, Acosta RD, Hernandez-Avila M,. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011; 378: 1868-73.